Immunosuppression maintenance therapy for lung transplantation

Immunosuppression maintenance therapy for lung transplantation refers to the lifelong pharmacologic management of individuals who have undergone single, bilateral, or heart-lung transplantation This post-transplant clinical state is characterized by constant vulnerability of the respiratory allograft to host immune recognition, driven by direct exposure of donor lung epithelial and vascular tissue to circulating host leukocytes and inhaled environmental antigens Standard maintenance protocols co...

Immunosuppression maintenance therapy for lung transplantation refers to the lifelong pharmacologic management of individuals who have undergone single, bilateral, or heart-lung transplantation

This post-transplant clinical state is characterized by constant vulnerability of the respiratory allograft to host immune recognition, driven by direct exposure of donor lung epithelial and vascular tissue to circulating host leukocytes and inhaled environmental antigens Without sustained immune modulation, recipient T-cell and antibody-mediated responses incite vascular and airway inflammation, culminating in acute cellular rejection, antibody-mediated rejection, or chronic lung allograft dysf...

Without sustained immune modulation, recipient T-cell and antibody-mediated responses incite vascular and airway inflammation, culminating in acute cellular rejection, antibody-mediated rejection, or chronic lung allograft dysfunction